Register for Industry Webcasts, White Papers Case Studies
White Paper Abstract: When drug benefit programs change, expert say, so do patientsí drug spending and
utilization behaviors. Confused by multi-tiered drug formularies and priced out of
higher co-pays for certain drugs, some patients forego filling their prescriptions altogether, a
decision that adversely affects outcomes and utilization costs. Thatís why support is growing
around the idea of benefit-based co-payments (BBCs)óreducing or eliminating prescription
co-pays for the sickest patients. This payment structure, first advocated in 2001 by Mark
Fendrick, M.D., professor of internal medicine at the University of Michigan Medical School,
links improvements in clinical outcomes with lowered out-of-pocket costs for patients.
Simply put, the higher a drugís clinical benefit to a patient, the lower that patientís co-pay.
In extreme cases, when drug adherence is critical
to treatment, some patients may even be paid to
take their medicine.
Please fill out the registration form below to receive "Benefit-based Co-pays: Paying Less For a Prescription When You Need It More" [Note: Incomplete and invalid forms will not be processed.]